Celltrion licenses in microbiome drug candidates from KoBioLabs

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-25 19:27 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, South Korea, Drugs, World News
--------------------------------------------------------------------
Snippet:
Celltrion said Wednesday it has signed a license-in agreement with Korean biopharma company KoBioLabs for three microbiome-based drug candidates targeting intestinal diseases.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]